Companies are increasingly citing artificial intelligence as justification for layoffs, according to a new analysis highlighting growing concerns about AI’s impact on the workforce. U.S.-based employers announced 83,387 job cuts in April, a 38 percent increase from March, according to a report released Thursday by Challenger, Gray & Christmas. Layoffs were still down 21 percent...
Companies are increasingly citing artificial intelligence as justification for layoffs, according to a new analysis highlighting growing concerns about AI’s impact on the workforce. U.S.-based employers announced 83,387 job cuts in April, a 38 percent increase from March, according to a report released Thursday by Challenger, Gray & Christmas. Layoffs were still down 21 percent...
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression and post-traumatic stress disorder (PTSD), the latest step by the Trump administration toward possible approval. The agency did not disclose the specific companies that were granted priority review vouchers. Two companies are studying psilocybin; one for treatment-resistant depression (TRD) and the other for treatment of major depressive disorder. A t
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression and post-traumatic stress disorder (PTSD), the latest step by the Trump administration toward possible approval. The agency did not disclose the specific companies that were granted priority review vouchers. Two companies are studying psilocybin; one for treatment-resistant depression (TRD) and the other for treatment of major depressive disorder. A third...